Oriola Oyj

OKDBV

FI0009014351

Pharmaceuticals

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
0.916 ^EUR	+0.33%		+1.22%	-15.81%

Jun. 06	Oriola Oyj Announces Board Appointments	CI
Apr. 30	Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale	MT

Oriola KD : -KD renews centralized sourcing service agreement for pharmacy chains in Sweden

January 20, 2015 at 09:02 am EST

Oriola-KD Corporation Stock Exchange Release 20 January 2015 at 4.00 p.m.

Oriola-KD renews centralized sourcing service agreement for pharmacy chains in Sweden

Oriola-KD Corporation ("Oriola-KD") has today renewed the agreement to provide centralized sourcing services for Apoteksgruppen and Lloyds Apotek pharmacy chains in Sweden. The renewed contract has been agreed to be valid until end of 2017.

Oriola-KD Corporation

Tuomas Itkonen
CFO

For further information, please contact:

Tuomas Itkonen
CFO
tel. +358 40 596 4004
email: tuomas.itkonen@oriola-kd.com

Sami Laine
Group Treasurer
tel. +358 40 638 0251

Distribution:
NASDAQ OMX Helsinki Ltd.
Key media

Released by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Oriola-KD Oyj via Globenewswire

HUG#1888329

Latest news about Oriola Oyj

Oriola Oyj Announces Board Appointments	Jun. 06	CI
Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale	Apr. 30	MT
ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB.	Apr. 28	CI
Transcript : Oriola Oyj, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Oriola Corporation Approves Dividend for the Financial Year Ending 31 December 2023, Payable on 11 April 2024	Mar. 19	CI
Oriola Oyj Proposes Dividend for the Financial Year Which Ended 31 December 2023, Be Paid on 11 April 2024	Feb. 16	CI
Transcript : Oriola Oyj, 2023 Earnings Call, Feb 16, 2024	Feb. 16
Oriola Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 16	CI
Swedish Watchdog Starts Phase Two Inquiry into Oriola’s Dose Dispensing Unit Sale	Jan. 31	MT
Eva Nilsson Bågenholm Not to Stand for Re-Election as Board of Directors of Oriola Corporation	Jan. 24	CI
Oriola Plans EUR35 Million Investment in Resource Planning, Warehouse Systems Upgrade	Jan. 10	MT
Oriola Oyj Reports Impairment Charges for the Third Quarter of 2023	23-10-31	CI
Transcript : Oriola Oyj, Nine Months 2023 Earnings Call, Oct 31, 2023	23-10-31
Oriola Oyj Announces Dividend Policy	23-10-31	CI
Oriola Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
ApotekstjÄNst Sverige Ab signed an agreement to acquire Svensk Dos AB from Oriola Oyj.	23-10-12	CI
Oriola Oyj(HLSE:OKDBV) dropped from S&P Global BMI Index	23-09-18	CI
Orion and Oriola to Continue Partnership in Finland	23-09-04	CI
Transcript : Oriola Oyj, H1 2023 Earnings Call, Jul 21, 2023	23-07-21
Oriola Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-21	CI
Oriola Oyj Announces Appointment of Niklas Lindholm, Ph. D. as Chief People Officer	23-05-23	CI
Transcript : Oriola Oyj, Q1 2023 Earnings Call, Apr 27, 2023	23-04-27
Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Oriola Oyj Approves Payment of Dividend for the Financial Year Ending 31 December 2022, Payable on 14 April 2023	23-03-21	CI

Chart Oriola Oyj

Duration

Period

More charts

Company Profile

Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.

Sector

Pharmaceuticals

Calendar

2024-07-18 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Oriola Oyj

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.916 EUR

Average target price

1.05 EUR

Spread / Average Target

+14.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
ORIOLA OYJ	-15.81%	186M
MCKESSON CORPORATION	+24.55%	74.8B
CARDINAL HEALTH, INC.	-6.59%	22.92B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.17%	8.74B
SINOPHARM GROUP CO. LTD.	-2.89%	7.94B
HUADONG MEDICINE CO., LTD	-33.14%	6.69B
H. LUNDBECK A/S	+22.28%	5.66B
EBOS GROUP LIMITED	-4.28%	4.02B
MEDIPAL HOLDINGS CORPORATION	+12.80%	3.41B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+6.92%	3.18B

Pharmaceuticals Wholesale

Oriola Oyj

Equities

OKDBV

FI0009014351

Pharmaceuticals

Oriola KD : -KD renews centralized sourcing service agreement for pharmacy chains in Sweden

EPS Revisions